MCMCB Pro
G9207

G9207Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

HCPCSTerminatedBETOS M5B

G9207 is a HCPCS Level II code for hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2016 and is not valid on new claims.

This code has been terminated

CMS terminated G9207 on December 31, 2016. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

The CMS record for G9207

Long descriptor
Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

The official wording. This is what the code means.

Short descriptor
Hep c genotype prior to med

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2014

When CMS introduced the code.

Terminated
December 31, 2016

When CMS retired it.

BETOS
M5B

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
00 — Not priced by Part B

Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.

Codes adjacent to G9207

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9207 is not quite right, the correct code is very often within a few positions of it.

  • G9199Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))terminated
  • G9200Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not giventerminated
  • G9201Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admissionterminated
  • G9202Patients with a positive hepatitis c antibody testterminated
  • G9203Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cterminated
  • G9204Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not giventerminated
  • G9205Patient starting antiviral treatmentfor hepatitis c during the measurement periodterminated
  • G9206Patient starting antiviral treatment for hepatitis c during the measurement periodterminated
  • G9208Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not giventerminated
  • G9209Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatmentterminated
  • G9210Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)terminated
  • G9211Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not giventerminated
  • G9212Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
  • G9213Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
  • G9214Cd4+ cell count or cd4+ cell percentage results documentedterminated
  • G9215Cd4+ cell count or percentage not documented as performed, reason not giventerminated

Questions about G9207

What is HCPCS code G9207?

G9207 is a HCPCS Level II code for hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G9207?

The CMS HCPCS file marks G9207 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

Is G9207 still valid?

No. G9207 was terminated on December 31, 2016 and should not be used on new claims.

HCPCS Level II2026Q3-Jul· effective July 1, 2026